ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì ½ÃÀå º¸°í¼­(2025-2033³â) : Á¦Ç° À¯Çü, ¿ëµµ, ÃÖÁ¾ ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚ, Áö¿ªº°
Single-Use Bioprocessing Market Report by Product Type, Application, End-Use, End-User, and Region 2025-2033
»óǰÄÚµå : 1792338
¸®¼­Ä¡»ç : IMARC
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 141 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,999 £Ü 4,208,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ® µîÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 3,999 £Ü 5,612,000
PDF & Excel (5 User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ Copy&Paste°¡ ºÒ°¡´ÉÇÕ´Ï´Ù. Àμâ´Â 5ºÎ±îÁö °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,999 £Ü 7,015,000
PDF & Excel (Corporate License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ Copy&Paste°¡ ºÒ°¡´ÉÇÕ´Ï´Ù. Àμâ´Â 5ºÎ±îÁö °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì ½ÃÀå ±Ô¸ð´Â 2024³â 187¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº ½ÃÀå ±Ô¸ð°¡ 2033³â¿¡´Â 721¾ï ´Þ·¯¿¡ À̸£°í, 2025-2033³â ¼ºÀå·ü(CAGR)Àº 15.39%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. ¸¸¼º ÁúȯÀÇ ¸¸¿¬, ±â¼ú Áøº¸ Áõ°¡, ÀǾàǰ ½ÂÀÎÀ̳ª »ý¹° Á¦Á¦ Áõ°¡ µîÀÌ ½ÃÀåÀ» °ßÀÎÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù.

ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì ±â¼úÀº ¹ÙÀÌ¿À ÀǾàǰÀÇ ¿©°ú, º¸Á¸, ¼¼Æ÷ ¹è¾ç, È¥ÇÕ ¹× Á¤Á¦¸¦ ÇÑ ¹ø¸¸ »ç¿ëÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. ºñ¿ë È¿À²ÀûÀÌ°í ½Ã°£À» Àý¾àÇÏ¿© À¯¿¬¼º°ú ¹ø°Å·Î¿òÀÌ ¾ø´Â Æó±â ´É·ÂÀ» Á¦°øÇÕ´Ï´Ù. º¹ÀâÇÑ ÇÁ·Î¼¼½º¸¦ »ý·«ÇÔÀ¸·Î½á »ý»ê¼ºÀ» Çâ»ó½ÃŰ°í ±âÁ¸ÀÇ ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º¿Í ºñ±³ÇÏ¿© °³ÀÎ °£ ±³Â÷ ¿À¿°ÀÇ À§ÇèÀ» ÁÙÀÔ´Ï´Ù. ÀÌ ¿Ü¿¡µµ ¿¡³ÊÁö, ¹èÁö ¼Òºñ ¹× ź¼Ò ¹ßÀÚ±¹À» ÁÙÀ̰í ö°­¿¡ ºñÇØ Áö¼Ó °¡´ÉÇÑ Á¦Á¶ °øÁ¤À» Á¦°øÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¹é½Å, ½Ä¹° ¼¼Æ÷ ¹è¾ç, ´ÜÀÏŬ·ÐÇ×üÀÇ È¿À²ÀûÀÎ Á¦Á¶¿¡ ÀÌ¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½ÌÀº ¼³Ä¡, °ËÁõ ¹× ¹®¼­È­¿¡ °É¸®´Â Àη°ú ½Ã°£À» ´ÜÃàÇÒ ¼ö Àֱ⠶§¹®¿¡ ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ ¼¼°èÀûÀ¸·Î Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì ½ÃÀå µ¿Çâ

ÇöÀç ´ç´¢º´, õ½Ä, °üÀý¿°, ¾Ï, °íÇ÷¾Ð, ½ÉÀå ¹ßÀÛ, ³úÁ¹Áß, ¸¸¼º Æó»ö¼º ÆóÁúȯ(COPD) µîÀÇ ¸¸¼ºÁúȯ¿¡ ´ëÇÑ À¯º´·üÀÌ ¼¼°èÀûÀ¸·Î »ó½ÂÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå ¼ºÀåÀ» Áö¿øÇÏ´Â Áß¿äÇÑ ¿äÀÎ Áß Çϳª°¡ µÇ°í ÀÖ½À´Ï´Ù. À̿ʹ º°µµ·Î ¼¼°èÀÇ ÀǾàǰ ½ÂÀΰú »ý¹°Á¦Á¦ Áõ°¡¿¡ ÀÇÇÑ ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡°¡ ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. °Ô´Ù°¡ °í±Þ °íºÐÀÚ Àç·á¿Í ÇÃ¶ó½ºÆ½ º¹ÇÕÀç·á·Î Á¦ÀÛµÈ Á¦Ç°Àº ÀÏü °­µµ°¡ Çâ»óµÇ¾î ³ôÀº Àα⸦ ¾ò°í ÀÖÀ¸¸ç »ê¾÷ ÅõÀÚÀÚ¿¡°Ô À¯¸®ÇÑ ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ ¿Ü¿¡µµ ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì ½Ã½ºÅÛÀÌ Á¦°øÇÏ´Â ³ëµ¿ ºñ¿ë, Àç·á ºñ¿ë ¹× ÅõÀÚ ºñ¿ë Àý°¨°ú °°Àº ´Ù¾çÇÑ ÀÌÁ¡ÀÌ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì¿¡¼­ ÀΰøÁö´É(AI), ¸Ó½Å·¯´×(ML), ºòµ¥ÀÌÅÍ ¼Ö·ç¼Ç µî ¿¡·¯¸¦ ¿¹ÃøÇϰí Á¤¹Ðµµ¸¦ Çâ»ó½Ã۱â À§ÇÑ ´Ù¾çÇÑ ±â¼úÀû Áøº¸°¡ µîÀåÇϸ鼭 ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ÀǾàǰÀ» Á¦Á¶ÇÒ ¶§ÀÇ »ý¹°Á¦Á¦ÀÇ ¹èÁö Á¶Á¦³ª ÃâÇÏ¿¡¼­ ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½ÌÀÇ È°¿ëÀÌ È®´ëµÇ°í ÀÖ´Â °Íµµ ¾çÈ£ÇÑ ½ÃÀå Àü¸ÁÀ» °¡Á®¿À°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½ÌÀº ±âÁ¸ÀÇ ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º¿¡ ºñÇØ ÀÌ»êȭź¼Ò(CO2)ÀÇ ¾çÀ» ÁÙÀÏ ¼ö ÀÖ¾î ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½ÌÀÇ Ã¤¿ëÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ¼¼°èÀûÀ¸·Î ÇコÄÉ¾î ½Ã¼³ÀÇ °³¼±À¸·Î ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½ÌÀÇ Ã¤¿ëÀÌ Áõ°¡Çϰí ÀÖ´Â °Íµµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼Ò°³

Á¦5Àå ¼¼°èÀÇ ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì ½ÃÀå

Á¦6Àå ½ÃÀå ³»¿ª : Á¦Ç° À¯Çüº°

Á¦7Àå ½ÃÀå ºÐ¼® : ¿ëµµº°

Á¦8Àå ½ÃÀå ºÐ¼® : ÃÖÁ¾ ¿ëµµº°

Á¦9Àå ½ÃÀå ³»¿ª : ÃÖÁ¾ »ç¿ëÀÚº°

Á¦10Àå ½ÃÀå ºÐ¼® : Áö¿ªº°

Á¦11Àå SWOT ºÐ¼®

Á¦12Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦13Àå Porter's Five Forces ºÐ¼®

Á¦14Àå °æÀï ±¸µµ

CSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global single-use bioprocessing market size reached USD 18.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 72.1 Billion by 2033, exhibiting a growth rate (CAGR) of 15.39% during 2025-2033. The growing prevalence of chronic diseases, increasing technological advancements, and rising number of drug approvals and biologics represent some of the key factors driving the market.

Single-use bioprocessing technology is designed for filtration, storage, cell culture, mixing, and purification of biopharmaceutical products for one-time use. It is cost-effective, timesaving, and provides flexibility and hassle-free disposal. It assists in increasing productivity by eliminating complex steps and reduces the risks of cross-contamination among individuals as compared to traditional bioprocessing. Besides this, it is beneficial in reducing energy, media consumption, and carbon footprint and providing a sustainable manufacturing process as compared to steel. It is utilized for the effective production of vaccines, plant cell cultivation, and monoclonal antibodies. As it also reduces the time of staff members for set-up, validation, and documentation, the demand for single-use bioprocessing technology is increasing across the globe.

Single-Use Bioprocessing Market Trends:

Presently, the rising prevalence of chronic diseases, such as diabetes, asthma, arthritis, cancer, hypertension, heart attack, stroke, and chronic obstructive pulmonary disease (COPD), among the masses across the globe represents one of the key factors supporting the growth of the market. Apart from this, the growing demand for single-use bioprocessing due to the increasing number of drug approvals and biologics around the world is positively influencing the market. Additionally, rising preferences of products manufactured from high-grade polymer materials and plastic composites, as they offer enhanced integral strength, is offering lucrative growth opportunities to industry investors. Besides this, various benefits offered by single-use bioprocessing systems, such as lower labor, material, and investment costs, are propelling the growth of the market. In addition to this, the emergence of various technological advancements, such as artificial intelligence (AI), machine learning (ML), and big data solutions in single-use bioprocessing for predicting errors and improving accuracy, is bolstering the growth of the market. Moreover, the growing utilization of single-use bioprocessing in media preparation and shipping of biologics while manufacturing pharmaceuticals is offering a favorable market outlook. In line with this, the rising adoption of single-use bioprocessing, as it reduces the amount of carbon dioxide (CO2) compared to traditional bioprocessing, is impelling the growth of the market. Furthermore, the increasing employment of single-use bioprocessing due to the improving healthcare facilities across the globe is contributing to the growth of the market.

Key Market Segmentation:

Product Type Insights:

Application Insights:

End-Use Insights:

End-User Insights:

Regional Insights:

Competitive Landscape:

Key Questions Answered in This Report

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Single-Use Bioprocessing Market

6 Market Breakup by Product Type

7 Market Breakup by Application

8 Market Breakup by End-Use

9 Market Breakup by End-User

10 Market Breakup by Region

11 SWOT Analysis

12 Value Chain Analysis

13 Porters Five Forces Analysis

14 Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â